Download

Full Text

See more details

X (1)

• Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2017. CA Cancer J Clin 67:1 (2017), 7–30.
• Slaughter, D.P., Southwick, H.W., Smejkal, W., Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:5 (1953), 963–968.
• Monnier, Y., Simon, C., Surgery versus radiotherapy for early oropharyngeal tumors: a never-ending debate. Curr Treat Options Oncol, 16(9), 2015, 42.
• de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:6 (2012), 607–615.
• Gillison, M.L., Zhang, Q., Jordan, R., Xiao, W., Westra, W.H., Trotti, A., et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30:17 (2012), 2102–2111.
• Ang, K.K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D.I., Nguyen-Tân, P.F., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:1 (2010), 24–35.
• Soo, K.C., Tan, E.H., Wee, J., Lim, D., Tai, B.C., Khoo, M.L., et al. Surgery and adjuvant adiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 93:3 (2005), 279–286.
• Parsons, J.T., Mendenhall, W.M., Stringer, S.P., Amdur, R.J., Hinerman, R.W., Villaret, D.B., et al. Squamous cellcarcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 94:11 (2002), 2967–2980.
• Nichols, A.C., Yoo, J., Hammond, J.A., Fung, K., Winquist, E., Read, N., et al. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)—study protocol for a randomized phase II trial. BMC Cancer, 13, 2013, 133.
• Rahmati, R., Dogan, S., Pyke, O., Palmer, F., Awad, M., Lee, N., et al. Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation. Head Neck 37:6 (2015), 800–807.
• Setton, J., Caria, N., Romanyshyn, J., Koutcher, L., Wolden, S.L., Zelefsky, M.J., et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 82:1 (2012), 291–298.
• Eisbruch, A., Harris, J., Garden, A.S., Chao, C.K., Straube, W., Harari, P.M., et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00–22). Int J Radiat Oncol Biol Phys 76:5 (2010), 1333–1338.
• Gupta, T., Agarwal, J., Jain, S., Phurailatpam, R., Kannan, S., Ghosh-Laskar, S., et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol 104:3 (2012), 343–348.
• Turner, M.T., Byrd, J.K., Ferris, R.L., Current role of surgery in the management of oropharyngeal cancer. J Oncol Pract 12:11 (2016), 1176–1183.
• Oliveira, M., Luís, A., Carvalho, E., Esteves, S., Sargento, I., Ferreira, M., et al. Latetoxicity and quality of life in oral cavity and oropharyngeal cancer survivors treated with chemoradiotherapy. J Clin Oncol, 28(Suppl. 15), 2010 9092–9092.
• Pedro, C., Mira, B., Silva, P., Netto, E., Pocinho, P., Mota, A., et al. EP-1082: Primary surgery vs. radiotherapy in early-stage oropharyngeal cancer: a single centre experience. Radiother Oncol, 123(Suppl. 1), 2017, S595.